Differential effects of histamine H 3 receptor inverse agonist thioperamide, given alone or in combination with the N-methyl-d-aspartate receptor antagonist dizocilpine, on reconsolidation and consolidation of a contextual fear memory in mice

Neuroscience

Volumn 193, Issue , 2011, Pages 132-142

  Charlier, Y ^a   Tirelli, E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Consolidation; Dizocilpine; Histamine H3 receptor; NMDA receptor; Reconsolidation; Thioperamide

Indexed keywords

DIZOCILPINE; HISTAMINE; HISTAMINE H3 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; THIOPERAMIDE;

AMNESIA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISRUPTIVE BEHAVIOR; FEAR MEMORY; FEMALE; MEMORY; MEMORY CONSOLIDATION; MEMORY RECONSOLIDATION; MOUSE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, CLASSICAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; FEAR; FEMALE; FREEZING REACTION, CATALEPTIC; HISTAMINE H3 ANTAGONISTS; MEMORY; MICE; MICE, INBRED C57BL; PIPERIDINES;

EID: 80052455232     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.034     Document Type: Article

References (72)

1. Alberini C.M. Mechanisms of memory stabilization: are consolidation and reconsolidation similar or distinct processes?. Trends Neurosci 2005, 28:51-56.
2. Alvarez E.O., Banzan A.M. The activation of histamine-sensitive sites of the ventral hippocampus modulates the consolidation of a learned active avoidance response in rats. Behav Brain Res 2008, 189:92-99.
3. Alvarez E.O., Ruarte M.B. Glutamic acid and histamine-sensitive neurons in the ventral hippocampus and the basolateral amygdala of the rat: functional interaction on memory and learning processes. Behav Brain Res 2004, 152:209-219.
4. Arrang J.M., Morisset S., Gbahou F. Constitutive activity of the histamine H3 receptor. Trends Pharmacol Sci 2007, 28:350-357.
5. Baldi E., Bucherelli C., Schunack W., Cenni G., Blandina P., Passani B. The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat. Neuropharmacology 2005, 48:246-251.
6. Bardgett M.E., Points M., Kleier J., Blankenship M., Griffith M.S. The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats. Neuropharmacology 2010, 59:492-502.
7. Bardgett M.E., Points M., Roflow J., Blankenship M., Griffith M.S. Effects of H3 antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats. Psychopharmacology 2009, 205:589-597.
8. Benarroch E.E. Histamine in the CNS: multiple functions and potential neurologic implications. Neurology 2010, 75:1472-1479.
9. Berlin M., Boyce C.W., de Lera Ruiz M. Histamine H3 receptor as a drug discovery target. J Med Chem 2011, 54:26-53.
10. Bernaerts P., Lamberty Y., Tirelli E. Histamine H3 antagonist thioperamide dose-dependently enhances memory consolidation and reverses amnesia induced by dizocilpine or scopolamine in a one-trial inhibitory avoidance task in mice. Behav Brain Res 2004, 154:211-219.
11. Brioni J.D., Esbenshade T.A., Runyan Garrison T.R., Bitner S.R., Cowart M.D. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease. J Pharmacol Exp Ther 2011, 336:38-46.
12. Brown R.E., Stevens D.R., Haas H.L. The physiology of brain histamine. Prog Neurobiol 2001, 63:637-672.
13. Bucherelli C., Baldi E., Mariottini C., Passani M.B., Blandina P. Aversive memory reactivation engages in the amygdala only some neurotransmitters involved in consolidation. Learn Mem 2006, 13:426-430.
14. Burban A., Faucard R., Armand V., Bayard C., Vorobjev V., Arrang J.M. Histamine potentiates N-methyl-d-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding site. J Pharmacol Exp Ther 2010, 332:912-921.
15. Bustos S.G., Maldonado H., Molina V.A. Midazolam disrupts fear memory reconsolidation. Neuroscience 2006, 139:831-842.
16. Camera K., Fernando Mello C.F., Ceretta A.P., Rubin M.A. Systemic administration of polyaminergic agents modulate fear conditioning in rats. Psychopharmacology 2007, 192:457-464.
17. Cangioli I., Baldi E., Mannaioni P.F., Bucherelli C., Blandina P., Passani M.B. Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur J Neurosci 2002, 16:521-528.
18. Chen Z., Zhao Q., Sugimoto Y., Fujii Y., Kamei C. Effects of histamine on MK801-induced memory deficits in radial maze performance in rats. Brain Res 1999, 839:186-189.
19. Da Silva W.C., Bonini J.S., Bevilaqua L.R., Izquierdo I., Cammarota M. Histamine enhances inhibitory avoidance memory consolidation through a H2 receptor-dependent mechanism. Neurobiol Learn Mem 2006, 86:100-106.
20. Dai H., Kaneko K., Kato H., Fujii S., Jing Y., Xu A., Sakurai E., Kato M., Okamura N., Kuramasu A., Yanai K. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci Res 2007, 57:306-313.
21. De Almeida M.A., Izquierdo I. Intracerebroventricular histamine, but not 48/80, causes post-training memory facilitation in the rat. Arch Int Pharmacodyn Ther 1988, 291:202-207.
22. Debiec J., LeDoux J.E. Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience 2004, 129:267-272.
23. Diergaarde L., Schoffelmeer A.N., De Vries T.J. Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories. Eur J Pharmacol 2008, 585:453-457.
24. Drutel G., Peitsaro N., Karlstedt K., Wieland K., Smit M.J., Timmerman H., Pænula P., Leurs R. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 2001, 59:1-8.
25. Esbenshade T., Fox G., Krueger K., Miller T., Kang C., Denny L., Witte D., Yao B., Pan L., Wetter J., Marsh K., Bennani Y., Cowart M., Sullivan J., Hancock A. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 antagonists with drug-like properties. J Pharmacol Exp Ther 2005, 313:165-175.
26. Faucard R., Armand V., Héron A., Cochois V., Schwarz J.C., Arrang J.M. N-methyl-d-aspartate receptor antagonists enhance histamine neuron activity in rodent brain. J Neuroschem 2006, 98:1487-1496.
27. Fell M.J., Katner J.S., Johnson B.G., Khilevich A., Schkeryantz J.M., Perry K.W., Svensson K.A. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge. Neuropharmacology 2010, 58:632-639.
28. Fitch T., Adams B., Chaney S., Gerlai R. Force transducer-based movement detection in fear conditioning in mice: a comparative study. Hippocampus 2002, 12:4-17.
29. Flood J.F., Uezu K., Morley J.E. Effect of histamine H2 and H3 receptor modulation in the septum on post-training memory processing. Psychopharmacology 1998, 140:279-284.
30. Fox G., Esbenshade T., Pan J., Radek R., Krueger K., Yao B., Browman K., Buckley M., Ballard M., Komater V., Miner H., Zhang M., Faghih R., Rueter L., Bitner R., Drescher K., Wetter J., Marsh K., Lemaire M., Porsolt R., Bennani Y., Sullivan J., Cowart M., Decker M., Hancock A. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy of a potent and selective histamine H3 receptor antagonist in cognition and schizophrenia. J Pharmacol Exp Ther 2005, 313:176-190.
31. Fox G.B., Pan J.B., Radek R.J., Lewis A.M., Bitner R.S., Esbenshade T.A., Faghih R., Bennani Y.L., Williams M., Yao B.B., Decker M.W., Hancock A.A. Two novel and selective non-imidazole H3 receptor antagonists A-304120 and A-317920: II. In vivo behavioural and neurophysiological characterization. J Pharmacol Exp Ther 2003, 305:897-908.
32. Gemkow M.J., Davenport A.J., Harich S., Ellenbroek B.A., Cesura A., Hallett D. The histamine H3 receptor as a therapeutic drug target for CNS disorders. Drug Discov Today 2009, 14:509-515.
33. Ghi P., Di Carlo G., Molinengo L. Effects of thioperamide on locomotor activity and memory processes. Prog Neuropsychopharm Biol Psychiatry 1998, 22:387-395.
34. Ghi P., Ferretti C., Orsetti M. Cognitive enhancing properties of thioperamide infused into the nucleus basalis magnocellularis of the rat. Inflamm Res 2001, 50:78-79.
35. Giovannini M.G., Efoudebe M., Passani M.B., Baldi E., Bucherelli C., Giachi F., Corradetti R., Blandina P. Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. J Neurosci 2003, 23:9016-9023.
36. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol Rev 2008, 88:1183-1241.
37. Hansen K.B., Mullasseril P., Dawit S., Kurtkaya N.L., Yuan H., Vance K.M. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-d-aspartate receptor antagonists. J Pharmacol Exp Ther 2010, 333:650-662.
38. Huang Y.W., Chen Z., Hu W.W., Zhang L.S., Wu W., Ying L.Y., Wei E.Q. Facilitating effect of histamine on spatial memory deficits induced by MK-801 as evaluated by 8-arm radial maze in Sprague-Dawley rats. Acta Pharmacol Sin 2003, 24:1270-1276.
39. Huang Y.W., Hu W.W., Chen Z., Zhang L.S., Shen H.Q., Timmerman H., Leurs R., Yanai K. Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav Brain Res 2004, 151:287-293.
40. Kim J.J., Jung M.W. Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci Biobehav Rev 2006, 30:188-202.
41. Komater V.A., Buckley M.J., Browman K.E., Bao Pan J.B., Hancock A.A., Decker M.W., Fox G.B. Effects of histamine H3 receptor antagonists in two models of spatial learning. Behav Brain Res 2005, 159:295-300.
42. Lee J.L., Everitt B.J., Thomas K.L. Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 2004, 304:839-843.
43. Lee J.L., Milton A.L., Everitt B.J. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci 2006, 26:10051-10056.
44. Ligneau X., Perrin D., Landais L., Camelin J.C., Calmels T.P., Berrebi-Bertrand I., Lecomte J.M., Parmentier R., Anaclet C., Lin J.S., Bertaina-Anglade V., la Rochelle C.D., d'Aniello F., Rouleau A., Gbahou F., Arrang J.M., Ganellin C.R., Stark H., Schunack W., Schwartz J.C. BF2649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther 2007, 320:365-375.
45. Lozada A., Munyao N., Sallmen T., Lintunen M., Leurs R., Lindsberg P.J., Pænula P. Postischemic regulation of central histamine receptors. Neuroscience 2005, 136:371-379.
46. Masuoka T., Kamei C. The ameliorating effects of NMDA receptor agonists on histamine H1 antagonist-induced memory and hippocampal theta disruptions are prevented by the H3 receptor agonist in rats. Brain Res Bull 2009, 79:422-425.
47. Masuoka T., Mikami A., Kamei C. Ameliorative effect of a hippocampal metabotropic glutamate-receptor agonist on histamine H1 receptor antagonist-induced memory deficit in rats. J Pharmacol Sci 2010, 113:41-47.
48. McGaugh J.L., Roozendaal B. Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology 2009, 202:3-14.
49. Meguro K., Yanai K., Sakai N., Sakurai E., Maeyama K., Sasaki H., Watanabe T. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol Biochem Behav 1995, 50:321-325.
50. Miller T.R., Milicic I., Bauch J., Du J., Surber B., Browman K.E., Marsh K., Cowart M., Brioni J.D., Esbenshade T.A. Use of H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists. Br J Pharmacol 2009, 157:139-149.
51. Molinengo L., Di Carlo G., Ghi P. Combined action of thioperamide plus scopolamine, diphenhydramine, or methysergide on memory in mice. Pharmacol Biochem Behav 1999, 63:221-227.
52. Morgado-Bernal I. Learning and memory consolidation: linking molecular and behavioral data. Neuroscience 2011, 10:12-19.
53. Nader K., Einarsson E.O. Memory reconsolidation: an update. Ann N Y Acad Sci 2010, 1191:27-41.
54. Nakazato E., Yamamoto E., Ohno M., Watanabe S. Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats. Life Sci 2000, 67:1139-1147.
55. Nielsen D.M., Crnic L.S. Automated analysis of foot-shock sensitivity and concurrent freezing behaviour in mice. J Neurosci Methods 2002, 115:199-209.
56. Nishiga M., Kamei C. Ameliorative effects of histamine on 7-chlorokynurenic acid-induced spatial memory deficits in rats. Psychopharmacology 2003, 166:360-365.
57. Orsetti M., Ferretti C., Gamalero R., Ghi P. Histamine H3-receptor blockade in the rat nucleus basalis magnocellularis improves place recognition memory. Psychopharmacology 2002, 159:133-137.
58. Orsetti M., Ghi P., Di Carlo G. Histamine H3-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task. Behav Brain Res 2001, 124:235-242.
59. Passani M.B., Blandina P. Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol Sci 2011, 32:242-249.
60. Passani M.B., Cangioli I., Baldi E., Bucherelli C., Mannaioni P.F., Blandina P. Histamine H3 receptor-mediated impairment of contextual fear conditioning and in vivo inhibition of cholinergic transmission in the rat basolateral amygdala. Eur J Neurosci 2001, 14:1522-1532.
61. Passani M.B., Giannoni P., Bucherelli C., Baldi E., Blandina P. Histamine in the brain: beyond sleep and memory. Biochem Pharmacol 2007, 73:1113-1122.
62. Pillot C., Héron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwarz J.C., Arrang J.M. A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain. Neuroscience 2002, 114:173-193.
63. Prast H., Argyriou A., Philippu A. Histaminergic neurons facilitate social memory in rats. Brain Res 1996, 734:316-318.
64. Privou C., Li J.S., Hasenöhrl R.U., Huston J.P. Enhanced learning by posttrial injection of H1-but not H2-histaminergic antagonists into the nucleus basalis magnocellularis region. Neurobiol Learn Mem 1999, 71:308-324.
65. Przybyslawski J., Sara S.J. Reconsolidation of memory after its reactivation. Behav Brain Res 1997, 84:241-246.
66. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003, 140:1-47.
67. Sotres-Bayon F., Bush D.E., LeDoux J.E. Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. Learn Mem 2004, 11:525-535.
68. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 2004, 24:4787-4795.
69. Tronson N.C., Taylor J.R. Molecular mechanisms of memory reconsolidation. Nat Rev Neurosci 2007, 8:262-275.
70. Xu L.S., Yang L.X., Hu W.W., Yu X., Ma L., Liu L.Y., Wei E.Q., Chen Z. Histamine ameliorates spatial memory deficits induced by MK-801 infusion into ventral hippocampus as evaluated by radial maze task in rats. Acta Pharmacol Sin 2005, 26:1448-1453.
71. Yates S.L., Phillips J.G., Gregory R., Pawlowski G.P., Fadnis L., Khan M.A., Ali S.M., Tedford C.E. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands. J Pharmacol Exp Ther 1999, 289:1151-1159.
72. Yokoyama F., Yamauchi M., Oyama M., Okuma K., Onozawa K., Nagayama T., Shinei R., Ishikawa M., Sato Y., Kakui N. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Psychopharmacology 2009, 205:177-187.